ALEXIS BLACK: Open Payments
NPI 1649943937 · LULING, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,017 in 42 payments from 24 companies in 2025. Trend: 2023 $1,816 · 2024 $2,203 · 2025 $3,017
Food & beverage: $2,983Speaker / faculty: $34
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $526 |
| Actelion Pharmaceuticals US, Inc. | 2 | $259 |
| Janssen Biotech, Inc. | 6 | $223 |
| Abbott Laboratories | 3 | $215 |
| Dexcom, Inc. | 2 | $177 |
| Madrigal Pharmaceuticals | 1 | $147 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $140 |
| Organon LLC | 1 | $138 |
| E.R. Squibb & Sons, L.L.C. | 2 | $137 |
| Edwards Lifesciences Corporation | 1 | $125 |
Products named: Wegovy, UPTRAVI, DEXCOM G7 GSS (161), FREESTYLE LIBRE 3, REZDIFFRA, Kerendia, VTAMA, Ozempic.
Industry payments across LA — which companies pay providers there.
